Elagolix and Myfembree are gonadotropin-releasing hormone (GnRH)-pathway therapies used for endometriosis, but their post-marketing safety reporting patterns remain incompletely characterized. Because spontaneous reporting databases are susceptible to reporting bias and …
We report an unexpected case of mesonephric-like adenocarcinoma initially treated as a diffuse adenomyosis in a patient presenting with primary infertility. The aim of this report is to raise clinical …
Background/Objectives: This study evaluates the 1-year follow-up outcomes after minimally invasive nerve-sparing surgery for the complete excision of deep endometriosis (DE), with a specific focus on deep dyspareunia. Cases with …
Clinical pearls into ACOG's postmenopausal bleeding guidelines with Susan Loeb-Zeitlin, MD, FACOG Contemporary OB/GYN
BBC newsreader scrolls on phone during live broadcast – but for an important reason newswav.com
BBC newsreader scrolls on phone during live broadcast – but for an important reason Newswav
Blood-based profiling could lead to earlier endometriosis care Contemporary OB/GYN
Dating app heavyweight enlisted to support FloHealth's global rise FemTech World
AstraZeneca removing breast cancer drug from Australia Australian Broadcasting Corporation
Rheumatic heart disease (RHD) remains a major cause of cardiovascular morbidity and premature mortality among children and young adults, particularly in low- and middle-income countries. Current management relies on antibiotic …